Paper39200230
Genetic and Epigenetic Biomarkers Associated with Early Relapse in Pediatric Acute Lymphoblastic Leukemia: A Focused Bioinformatics Study on DNA-Repair Genes.
Albaqami WF and 8 others. Biomedicines, 2024. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Genetic and Epigenetic Biomarkers Associated with Early Relapse in Pediatric Acute Lymphoblastic Leukemia: A Focused Bioinformatics Study on DNA-Repair Genes. Papers, record 39200230. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39200230
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genetic and Epigenetic Biomarkers Associated with Early Relapse in Pediatric Acute Lymphoblastic Leukemia: A Focused Bioinformatics Study on DNA-Repair Genes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| IFKSUDR_H164 | Deputyship for Research and Innovation, "Ministry of Education" in Saudi Arabia | PubMed |
Source PubMed
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,181,991 | Human DNA repair genes. | Science | 2001 | https://conductscience.org/library/papers/11181991 | PubMed |
| 2 | 36,902,091 | Pediatric Acute Lymphoblastic Leukemia Emerging Therapies-From Pathway to Target. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902091 | PubMed |
| 3 | 21,741,842 | miRNA response to DNA damage. | Trends Biochem Sci | 2011 | https://conductscience.org/library/papers/21741842 | PubMed |
| 4 | 33,628,188 | DNA Repair Pathways in Cancer Therapy and Resistance. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33628188 | PubMed |
| 5 | 21,908,496 | Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. | Ann Oncol | 2012 | https://conductscience.org/library/papers/21908496 | PubMed |
| 6 | 24,448,423 | Poly (ADP-ribose) polymerase 1 transcriptional regulation: a novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1-mutated ovarian cancer. | Oncotarget | 2014 | https://conductscience.org/library/papers/24448423 | PubMed |
| 7 | 27,067,600 | HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity. | Mol Cell | 2016 | https://conductscience.org/library/papers/27067600 | PubMed |
| 8 | 34,034,913 | Clinical features and prognostic impact of TCF3-PBX1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China. | Curr Probl Cancer | 2021 | https://conductscience.org/library/papers/34034913 | PubMed |
| 9 | 32,850,313 | Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned? | Front Oncol | 2020 | https://conductscience.org/library/papers/32850313 | PubMed |
| 10 | 33,054,110 | Pediatric acute lymphoblastic leukemia. | Haematologica | 2020 | https://conductscience.org/library/papers/33054110 | PubMed |
| 11 | 35,070,996 | Aberrant Expression of miR-1301 in Human Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/35070996 | PubMed |
| 12 | 34,529,761 | PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome. | Blood Adv | 2021 | https://conductscience.org/library/papers/34529761 | PubMed |
| 13 | 29,214,031 | PARP inhibitors as potential therapeutic agents for various cancers: focus on niraparib and its first global approval for maintenance therapy of gynecologic cancers. | Gynecol Oncol Res Pract | 2017 | https://conductscience.org/library/papers/29214031 | PubMed |
| 14 | 18,675,941 | Comparison of nonhomologous end joining and homologous recombination in human cells. | DNA Repair (Amst) | 2008 | https://conductscience.org/library/papers/18675941 | PubMed |
| 15 | 17,495,966 | Elevated mRNA transcripts of non-homologous end-joining genes in pediatric acute lymphoblastic leukemia. | Leukemia | 2007 | https://conductscience.org/library/papers/17495966 | PubMed |
| 16 | 29,415,318 | Association of AlkB homolog 3 expression with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma. | J Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/29415318 | PubMed |
| 17 | 18,720,757 | Molecular mechanisms involved in chemoresistance in paediatric acute lymphoblastic leukaemia. | Srp Arh Celok Lek | 2008 | https://conductscience.org/library/papers/18720757 | PubMed |
| 18 | 38,040,599 | Causes and consequences of DNA single-strand breaks. | Trends Biochem Sci | 2024 | https://conductscience.org/library/papers/38040599 | PubMed |
| 19 | 23,762,867 | Hypomethylation of ETS transcription factor binding sites and upregulation of PARP1 expression in endometrial cancer. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/23762867 | PubMed |
| 20 | 11,832,206 | Apoptosis: a link between cancer genetics and chemotherapy. | Cell | 2002 | https://conductscience.org/library/papers/11832206 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40,980,067 | Prognostic significance and pathogenesis of RFC3 gene expression in diffuse large B-cell lymphoma. | PeerJ | 2025 | https://conductscience.org/library/papers/40980067 |
Source PubMed
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALKBH3 | 221,120 | PubTator's text mining | https://conductscience.org/library/genes/221120 | NCBI Gene |
| NHEJ1 | 79,840 | PubTator's text mining | https://conductscience.org/library/genes/79840 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39200230
GET https://conductscience.org/api/papers/v1/39200230/references?page=2